Cyclic Peptides, Amides and D-Amino Acids on a Certificate

Several compounds in a research catalogue are not plain linear peptides: they are cyclic, or they carry a capped terminus, or they contain residues that are not among the standard twenty. Each of those features changes what a certificate has to demonstrate, and each creates a specific way for a lot to be wrong while still looking fine on a purity line.

Cyclic peptides

PT-141 (bremelanotide) is a cyclic peptide: its backbone is closed through a lactam bridge between two side chains. Cyclisation is a chemical step like any other, and it can fail.

• The linear precursor weighs more. Forming the ring eliminates a water molecule, so the cyclic product is 18 Da lighter than the uncyclised chain. That difference is the single most useful thing on the identity result for a cyclic compound: a mass 18 Da high means uncyclised material.
• Dimers and oligomers. Instead of closing on itself, a chain can couple to its neighbour. These show up as peaks at roughly double the expected mass.
• Retention time. A constrained ring is usually more compact than its linear form and often elutes differently, so a chromatogram with two close peaks may be showing cyclic and linear material side by side.

A certificate that reports only a purity percentage cannot tell you whether the main peak is the cyclic compound or its linear precursor. For this class, the identity result is not optional.

C-terminal amides

Many research peptides are supplied as C-terminal amides rather than free acids, because the amide is what the natural sequence has. The difference is 1 Da — small, but visible to a mass spectrometer and chemically meaningful. A report showing the free-acid mass for a compound specified as an amide is describing different material.

Non-standard residues

SS-31 (elamipretide) is a four-residue peptide containing D-arginine and 2,6-dimethyltyrosine — a D-amino acid and a modified aromatic residue. Two points follow:

• Mass alone cannot distinguish D from L. A D-amino acid has exactly the same mass as its L counterpart, so a mass result cannot confirm the correct stereochemistry. Chiral analysis is a separate test, and routine certificates do not include it.
• Modified residues must be in the expected mass. The dimethyl groups add mass; a result matching plain tyrosine indicates a different compound.

Short, highly basic sequences like this also carry a larger proportion of counter-ion by weight than longer peptides, which is worth remembering when comparing label weight with measured content. See counter-ions and net peptide content.

What to ask for, by feature

1. Cyclic: an identity result, checked against the cyclic mass rather than the linear one.
2. Amidated: an identity result that matches the amide, not the free acid.
3. D-amino acids: accept that mass cannot confirm stereochemistry, and ask whether chiral analysis was done if it matters for your work.
4. Any of the above: the chromatogram, not just the percentage — a close second peak is where the failed variant shows up.

Our guide on how mass spectrometry confirms identity covers how these results are produced.

Our lots in this group

PT10 (PT-141), SS31 (elamipretide), KPV and DSIP are each published with the figures the laboratory reported for the shipping lot, with verification links, on their product pages and on the lab results page. Where an analysis did not cover something — chiral purity, for instance — we do not imply that it did.

Materials supplied by BMS Labs are for laboratory research use only and are not for human or veterinary use. This page describes analytical documentation only and makes no claims about biological effects.